Call Options

18 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$67.3 - $69.67 $2.15 Million - $2.23 Million
32,000 Added 71.43%
76,800 $5.35 Million
Q2 2024

Aug 15, 2024

SELL
$66.47 - $69.65 $6.85 Million - $7.17 Million
-103,000 Reduced 69.69%
44,800 $3.01 Million
Q1 2024

May 07, 2024

BUY
$56.67 - $69.36 $6.68 Million - $8.18 Million
117,900 Added 394.31%
147,800 $10.2 Million
Q4 2023

Feb 14, 2024

BUY
$49.38 - $63.75 $1.48 Million - $1.91 Million
29,900 New
29,900 $1.86 Million
Q1 2023

May 16, 2023

SELL
$52.6 - $67.34 $405,020 - $518,518
-7,700 Reduced 63.11%
4,500 $245,000
Q4 2022

Feb 14, 2023

SELL
$59.56 - $76.6 $530,084 - $681,740
-8,900 Reduced 42.18%
12,200 $762,000
Q3 2022

Nov 14, 2022

BUY
$57.96 - $78.12 $747,684 - $1.01 Million
12,900 Added 157.32%
21,100 $1.49 Million
Q2 2022

Aug 15, 2022

BUY
$39.5 - $64.42 $59,250 - $96,630
1,500 Added 22.39%
8,200 $465,000
Q1 2022

May 16, 2022

SELL
$43.74 - $62.76 $170,586 - $244,764
-3,900 Reduced 36.79%
6,700 $419,000
Q4 2021

Feb 14, 2022

SELL
$50.01 - $73.35 $340,068 - $498,779
-6,800 Reduced 39.08%
10,600 $594,000
Q3 2021

Nov 15, 2021

SELL
$59.21 - $78.66 $1.14 Million - $1.52 Million
-19,300 Reduced 52.59%
17,400 $1.13 Million
Q2 2021

Aug 11, 2021

BUY
$51.39 - $66.9 $25,695 - $33,450
500 Added 1.38%
36,700 $2.33 Million
Q1 2021

May 17, 2021

SELL
$49.14 - $59.89 $304,668 - $371,318
-6,200 Reduced 14.62%
36,200 $2.17 Million
Q4 2020

Feb 16, 2021

SELL
$42.19 - $51.5 $4.78 Million - $5.83 Million
-113,300 Reduced 72.77%
42,400 $2.12 Million
Q3 2020

Nov 16, 2020

BUY
$35.33 - $51.04 $3.2 Million - $4.62 Million
90,600 Added 139.17%
155,700 $7.95 Million
Q2 2020

Aug 14, 2020

SELL
$22.91 - $39.83 $636,898 - $1.11 Million
-27,800 Reduced 29.92%
65,100 $2.29 Million
Q1 2020

May 15, 2020

BUY
$16.44 - $37.73 $1.02 Million - $2.35 Million
62,300 Added 203.59%
92,900 $2.36 Million
Q4 2019

Feb 14, 2020

BUY
$19.57 - $28.96 $598,842 - $886,176
30,600 New
30,600 $848,000

Others Institutions Holding AXNX

About Axonics, Inc.


  • Ticker AXNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 49,123,600
  • Market Cap $3.49B
  • Description
  • Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...
More about AXNX
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.